Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

Market Cap	7.25B
Revenue (ttm)	1.04B +135.8%
Net Income	244.61M +80.9%
EPS	3.92 +78.0%
Shares Out	72.79M
PE Ratio	25.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130,673
Open	99.54
Previous Close	101.57
Day's Range	99.54 - 99.54
52-Week Range	69.18 - 133.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopi...

• Industry: Specialty Outpatient Facilities, Not Elsewhere Classified
• Founded: 2009
• Employees: 117
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GAUDIUMIVF

Financial Performance

In fiscal year 2026, NSE:GAUDIUMIVF's revenue was 1.04 billion, an increase of 47.56% compared to the previous year's 707.24 million. Earnings were 244.61 million, an increase of 27.88%.